Navigation Links
Daiichi Sankyo and Ranbaxy Confirm Deal Is Binding and Final, Allay Market Rumour and Speculation
Date:7/16/2008

TOKYO, and NEW DELHI, India, July 17 /PRNewswire/ -- Following intense speculation in sections of the media and the stock market, Daiichi Sankyo Company, Limited (TSE: 4568.JP) ("Daiichi Sankyo") and Ranbaxy Laboratories Limited (NSE/BSE: Ranbaxy/500359) ("Ranbaxy") reiterate that the agreement between Daiichi Sankyo, Ranbaxy and the Singh family, the largest controlling shareholders of Ranbaxy, is binding and final, subject to regulatory approvals.

Daiichi Sankyo, Ranbaxy and the Singh family remain committed to the transaction and to the vision of creating a complementary business combination that provides sustainable growth by diversification and an enhanced global reach. Daiichi Sankyo, Ranbaxy and the Singh family stand by the deal and confirm that the terms of the deal remain unchanged. All the synergies expected to accrue to the combine, remain intact as before.

The Share Purchase and Share Subscription Agreement has earlier been unanimously approved by the Boards of Directors of both companies. Coupled with the approval now in place from the shareholders, this clears the decks for the deal to proceed as planned.

About Daiichi Sankyo Company, Limited

Daiichi Sankyo Company, Limited, established in 2005 after the joint share transfer of two leading century-old Japanese pharmaceutical companies, is continuously generating innovative drugs that enrich the quality of life for patients around the world. The company uses its cumulative knowledge and expertise in the fields of cardiovascular disease, cancer, metabolic disorders, and infection as a foundation for developing an abundant product line-up and R&D pipeline.

For more information, visit ( http://www.daiichisankyo.com/ )

About Ranbaxy Laboratories Limited

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company pr
'/>"/>

SOURCE Daiichi Sankyo Company, Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
2. Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
3. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
4. DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin
5. Ranbaxy Gains Tentative Approval to Manufacture and Market Valganciclovir Hydrochloride Tablets
6. Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
7. Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules
8. Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case
9. Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
10. Brazilian Sugarcane Industry: OECD Report Confirms Overall Benefits of Brazilian Sugarcane Ethanol
11. ATS Medical Confirms Excellent Durability of the ATS Open Pivot Mechanical Heart Valve

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Nov. 24 /PRNewswire-Asia/ -- NOD Pharmaceuticals ...e (PTO) has allowed the patent application for,its..., NOD technology is a highly efficient appr...adhesive nano-particles to enable oral delivery of...echnology is a platform technology,that can be app...
(Date:11/24/2009)...e FBI recently approved the Promega PowerPlex 16 H...or generating DNA records for the National DNA Ind...USA (PRWEB) -- The FBI recently approved the Prome...tories participating in, or generating DNA records...urrently contains more than seven million profiles...
(Date:11/24/2009)...ov. 24, 2009 Arena Pharm...y that the company is scheduled to present at the ...n December 1, 2009 at 11:30 a.m. Eastern Time (8:3...in New York City. Jack Lief, Arena,s President and...an overview of the company, including its clinical...
(Date:11/24/2009)...emical Abstracts Service (CAS), the global expert ...nt office is now the world,s leading producer of p...railed Japan,s patent office, the World Intellectu...ates Patent and Trademark Office (USPTO) for more ...in 2006, and exceeded Japan for the first time on ...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
...,(Nasdaq: GENZ ) has announced findings from an i...and patient satisfaction following,viscosupplement...nts with,osteoarthritis of the knee. This landmark...nee pain relief and a higher rate of patient satis... Raghu Raman and a team of doctors,from the Depart...
...uticals, Inc. (Nasdaq: MBRK ), a pharmaceutical c...ovel anti-infective products, today,announced that...lenTactics,LLC to lead its field force hiring effo...moxicillin extended-release tablets, 775mg) launch...9., MiddleBrook President and CEO John Thievon co...
...008 Third Quarter and 5% for the 2008 Fir...th in Pharmaceuticals Division Led by Sol...evnar +13% , - Guidance for 2008 Full Year D...ems, Revised to a Range of $3.49 to $3.55 , ...SON, N.J., Oct. 22 Wyeth (NYSE: WYE ),today repo...
Other Biology Technology:Independent Study Reveals SYNVISC(R) Offers Longer Knee Pain Relief and Greater Patient Satisfaction for Those Suffering from Osteoarthritis of the Knee 2Independent Study Reveals SYNVISC(R) Offers Longer Knee Pain Relief and Greater Patient Satisfaction for Those Suffering from Osteoarthritis of the Knee 3MiddleBrook Hires TalenTactics to Recruit National Field Force 2MiddleBrook Hires TalenTactics to Recruit National Field Force 3Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 2Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 3Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 4Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 5Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 6Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 7Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 8Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 9Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 10Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 11Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 12Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 13Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 14
(Date:11/26/2009)...ed deer have been caught in the hunters, sights fo...than decorative. They are lethal weapons that stag...The University of York, UK, has been intrigued by ...century and has become fascinated by the mechanica...laboration with Tomas Landete-Castillejos at the U...
(Date:11/26/2009)... are the bare essentials of life, the indispensabl...survive on its own? Can we describe the molecular ...ganism functions as a system? These are just some ...between the European Molecular Biology Laboratory ...egulacio Genmica (CRG) in Barcelona, Spain, set ou...
(Date:11/25/2009)...lives. In addition to mammalian immune systems tha...ed bacteriophages, viruses that kill half the bact... and another class of microorganisms called archae...s deep-sea volcanic vents) manage just fine, thank... system that helps protect them from many viruses ...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Nationwide Relocation Services Support Breast Cancer Awareness 61210 1Nationwide Relocation Services Support Breast Cancer Awareness 61210 2Nationwide Relocation Services Support Breast Cancer Awareness 61210 3SourceMedical Earns Cardinal Health Innovation Award 61207 1SourceMedical Earns Cardinal Health Innovation Award 61207 2Fresh Throne Eco Friendly Bathroom Spray Celebrates Launch by Donating to Salvation Army 61204 1Fresh Throne Eco Friendly Bathroom Spray Celebrates Launch by Donating to Salvation Army 61204 2
...ratory researchers explore new frontier of metabol...ntists genetic roadmaps to link certain genes to d... by certain genes spawned the field of proteomics....ent of Energy,s Ames Laboratory at Iowa State Univ...ing to begin understanding the chemical processes ...
...of above-ground nuclear testing provide a way to d...arbon-14 produced by above-ground nuclear testing ...tists with a more precise way to determine a perso...lp in the identification of victims of Hurricane K...technique, developed by researchers at Lawrence Li...
...ia is a hereditary blood disease, primarily affect...otentially life-threatening ,bleeds,. About one in... severe, moderate or mild form. People with haemop...Factor VIII clotting protein. , Professor Denisa W...breaking discoveries that provide hope of an alter...
Other Biology News:Making plant cells work like miniature factories 2Making plant cells work like miniature factories 3New tooth enamel dating technique could help identify disaster victims 2New tooth enamel dating technique could help identify disaster victims 3Promising therapies for haemophilia & heart disease 2
Rabbit Anti-JNK1, phospho (Thr183 / Tyr185) Polyclonal Antibody, Unconjugated from Abcam
Cytofix Buffer from BD Biosciences Pharmingen
Perm/Wash Buffer from BD Biosciences Pharmingen
BD Phosflow Fix Buffer I from BD Biosciences Pharmingen
Biology Products: